About Conference Welcome Message Program Committee Hotel and Venue Location and Transportation Past Event Report

Why Speak? For Your Visa Who Should Attend? Contact Us Program Key Dates Schedule Program Social Events Participant Abstract Information Meeting Proceeding Participant Guideline Submission Guidelines Sponsorship and Exhibition Sponsorship Opportunities Exhibition Poster Application Registration Registration Information Price Registration Now Cancellations Press & media Call for Media Partners Media Partner List Optional Tour Tech Tour Partial Scenery of Tour Participants List (Academia)-2010 Ain-Shams University, Egypt Akershus University Hospital, Norway Albany Medical College, USA Albert Eintein College of Medicine, Beth Israel Medicine, USA Altai State Technical University, Russia American Heart Association, USA Antwerp University Hospital, Antwerp, Belgium Participants List (Business)-2010 A*STAR, Singapore Abbott Park, USA Addex Pharmaceuticals, Switzerland ?terna Zentaris, Germany Agilent Technologies, USA Alacrita LLP, UK AstraZeneca Pharmaceuticals LP, USA AstraZeneca KK, Japan Avanti Group of Companies, USA

Chapter 5: Leading Drug Discovery Technology

Session 5-1: Lab-On-a-Chip/Microfluidics Chair: 13:30-13:55 13:55-14:20 14:20-14:45 14:45-15:10 15:10-15:30 15:30-15:55 Call for Host Title: Novel Strategy for Non-traditional Therapeutic Discovery Dr. Xianbin Yang, Director, Research and Development, AMBiotech, USA Speech Opportunity Available Title: Ion Channel Drug Screening Platform: Planar Patch-Clamp Chip Integrated with On-Demand Drug Exchange Chip Dr. De-Shien Jong, Associate Professor, National Taiwan University, Taiwan Title: Microfluidic Study of Detoxification by Kidney Proximal Tubular Cells Dr. Partha Roy, Assistant Professor, National University of Singapore, Singapore Coffee Break Title: Cancer Cell Separation Based on Dielectrophoresis in Microfluidics Dr. Guiren Wang, Assistant Professor, Department of Mechanical Engineering & Biomedical Engineering Program, University of South Carolina, USA Title: TBD Dr. Claus-Dieter Ohl, Assistant Professor, School of Physical and Mathematical Sciences (SPMS), Division of Physics and Applied Physics (PAP), Nanyang Technological University (NTU), Singapore

15:55-16:20

Session 5-2: Biochips and Microarray Technology in Drug Discovery Chair: 13:30-13:55 13:55-14:20 14:20-14:45 14:45-15:10 15:10-15:30 15:30-15:55 Call for Host Title: TBD Dr. Pankaj Agarwal, Director, Computational Biology, Bioinformatics at GlaxoSmithKline, USA Speech Opportunity Available Title: Employment of Quantitative Light Microscopy in Identification of a Novel Metastasis Suppressor, Protein 4.1B, Controlling Morphology, Motility, Chemotaxis and Invasion Dr. Daniel Zicha, Head of Light Microscopy, Cancer Research, UK Title: Waveguide Micro-Optics for Point-of-Care Diagnostics Dr. William Parker, Director of Technology, Creative Microsystems Inc., USA Coffee Break Title: Role of Optical Imaging in Drug Disovery Dr. Britto Sandanaraj Selvaraj, Senior Scientist, Novartis Institutes for BioMedical Research, Novartis Institutes for BioMedical Research, Inc., USA Title: Molecular Serum Portraits Predictive of Cancer can be Deciphered by Affinity Proteomics Dr. Carl A.K. Borrebaeck, Professor, Deputy Vice-chancellor, Department of Immunotechnology, Lund University, Sweden

15:55-16:20

Session 5-3: Liquid Chromatography in Drug Discovery Chair: 13:30-13:55 13:55-14:20 14:20-14:45 14:45-15:10 Call for Host Speech Opportunity Available Title: TBD Dr. Sihe Wang, Section Head, Clinical Biochemistry, Clinical Pathology, Cleveland Clinic, USA Speech Opportunity Available Title: Applying Quality by Design Principles to the Development and Validation of Analytical Methods Dr. Melissa Hanna-Brown, Associate Research Fellow, Pfizer Global R+D Labs Sandwich, UK Coffee Break

15:10-15:30 The continued program will be released soon Session 5-4: MS, LC-MS in Drug Discovery Chair: 13:30-13:55 13:55-14:20 14:20-14:45 14:45-15:10 15:10-15:30 15:30-15:55

Call for Host Title: Clinical Tracer Studies for Discovery and Development Dr. Graeme Young, Manager, Drug Metabolism and Pharmacokinetics (PTS-DMPK), GlaxoSmithKline Research and Development Ltd., UK Title: LC-MS/MS Assays for Peptides and Proteins in Drug Discovery and Development Dr. Jaap Wieling, Vice President, Bioanalysis and Technology R&D, QPS, The Netherlands Speech Opportunity Available Title: Towards Standard-free Quantitative and Qualitative Analysis in Liquid Chromatography Dr. Wulff Niedner, Manager, LC Products, Dionex Corporation, Germany Coffee Break Title: The Use of LC-MS/MS in the High-Throughput Assessment of P450 Inhibition via a Seven Probe Substrate Cocktail Dr. Jennifer Otten, Associate Scientist, Array BioPharma, USA

Chair: Co-Chair:

Dr. Zhong Zhong, Sr. Director of Discovery Technology, GlaxoSmithKline RD, China

Dr. Eugenii (Ilan) A. Rabiner, Head, Clinical Imaging Applications, GSK Clinical Imaging Centre, UK (To be confirmed soon)

13:30-13:55 13:55-14:20 14:20-14:45 14:45-15:10 15:10-15:30 15:30-15:55 15:55-16:20 16:20-16:45 16:45-17:10

Keynote Speech Title: From the Cell to the Animal to the Human - Translational NIR Biomarker Imaging Dr. Achim von Leoprechting, Vice President & General Manager, Imaging & Detection Technologies, Germany Speech Opportunity Available Title: Cell Imaging Assays in Drug Discovery Dr. Zhong Zhong, Senior Director of Discovery Technology, GlaxoSmithKline RD, China Title: TBD Dr. Wendol A. Williams, Associate Medical Director, Yale PET Center, USA Coffee Break Title: Reducing Early-phase Attrition Through the Use of Translational Molecular Imaging Dr. Eugenii (Ilan) A. Rabiner, Head, Clinical Imaging Applications, GSK Clinical Imaging Centre, UK Title: TBD Dr. Aniket D. Joshi, Imaging, Merck Research Laboratories, USA Title: Molecular Imaging in Drug Delivery and Drug Discovery Dr. Rao Papineni, Distinguished Scientist and Senior Principal Investigator, Research and Development, Carestream Molecular Imaging, USA Title: Dendritic Prodrug or DrugTree, a Novel Platform for Drug Delivery Dr. Minghui Chai, Associate Professor, Department of Chemistry, Central Michigan University, USA

About Conference Welcome Message Program Committee Hotel and Venue Location and Transportation Past Event Report Why Speak? For Your Visa Who Should Attend? Contact Us Program Key Dates Schedule Program Social Events Participant Abstract Information Meeting Proceeding Participant Guideline Submission Guidelines Sponsorship and Exhibition Sponsorship Opportunities Exhibition Poster Application Registration Registration Information Price Registration Now Cancellations Press & media Call for Media Partners Media Partner List Optional Tour Tech Tour Partial Scenery of Tour Participants List (Academia)-2010 Ain-Shams University, Egypt Akershus University Hospital, Norway Albany Medical College, USA Albert Eintein College of Medicine, Beth Israel Medicine, USA Altai State Technical University, Russia American Heart Association, USA Antwerp University Hospital, Antwerp, Belgium Participants List (Business)-2010 A*STAR, Singapore Abbott Park, USA Addex Pharmaceuticals, Switzerland ?terna Zentaris, Germany Agilent Technologies, USA Alacrita LLP, UK AstraZeneca Pharmaceuticals LP, USA AstraZeneca KK, Japan Avanti Group of Companies, USA

Highlights of the Conference 15 Chapters Rethink Drug Innovations from Upstream to Downstream 7 Satellite Conferences Facilitating with the Brainstorm of Drug Discovery Science 3 Special Symposia First Focus on Non-Human Drug Discovery 50+ Exhibition Booths Showcasing New Products and New Technologies 2000+ Targeted Audiences from Worldwide Enlarged Meeting Influence Keynote Speakers Dr. Thomas A.Steitz, The Nobel Prize Laureate in Chemistry 2009, Sterling Professor of Molecular Biophysics and Biochemistry, Yale University, USA Dr. Ada E.Yonath, The Nobel Prize Laureate in Chemistry 2009; Director, Weizmann Institute of Science, Israel Renowned Speakers Dr. Frida Grynspan, Vice President of Research & Development, Pluristem Therapeutics Inc., USA Dr. Huifen Faye Wang, Director, Clinical Pharmacology, Emerging Markets Business Unit, Pfizer, Inc., USA Dr. Jerzy E Tyczynski, Director, Global Medical Services, Global Pharmaceutical R&D, Abbott Laboratories, USA Dr. Jacob de Vlieg, Global Head Molecular Design & Informatics, MSD, Merck, The Netherlands Dr. Barry A Morgan, Vice President, Molecular Discovery Research, GlaxoSmithKline, USA Dr. Rolf G. Werner, Senior VP, Corporate Division Biopharmace, Boehringer Ingelheim Gmbh, Germany Save up to $50 Register before 15th July First Round Program Released

Conference on International Exchange of Professionals (CIEP)

Dr. Scott Simonet, Vice President, Metabolic Disorders Research, Amgen, USA

Dr. Bahija Jallal, Vice President, Medimmune, Inc, USA

BITs 2nd Annual World Congress of NanoMedicine- 2011

BIT's 1 Annual Symposium of Drug Delivery Systems Dr. Michael Hennig, Vice Director & Head, Discovery Technologies, F. Hoffmann-La Roche Ltd., Switzerland Dr. Parviz Ghahramani, Executive Director, Head of Clinical Pharmacology, Forest Research Institute, USA Dr. Oliver Steinbach, Senior Director, Department Bio-Molecular Engineering at Philips Research, the Netherlands

st

BIT's 1 World Congress of Small RNAs-2011

st

BIT's 1 New Energy Forum

st

Dr. Jin Li, Director of Global Compound Sciences, AstraZeneca PLC, UK

Information Research Center of International Talents, SAFEA

Programmed Chapters at a Glance

Part 1: Basic Sciences in Drug Discovery

Chapter 1: Drug Discovery Biology and Biotechnology Chapter 2: Drug Target Discovery and Validation Chapter 3: Drug Screening Technology Chapter 4: Rational Drug Design Chapter 5: Leading Drug Discovery Technology

China Medical Biotech Association State Administration of Foreign Experts Affairs Shenzhen Municipal People's Government

Part 2: Early Phase Drug Discovery-Upstream

Chapter 6: Frontier in Small Molecule Drug Discovery Chapter 7: Breaking Biotherapy Discovery Chapter 8: Genome-Based Drug Discovery and Development Chapter 9: Traditional Chinese Medicine vs Natural Product based Drug Discovery BIT Congress, Inc. Foreign Experts Databank of SAFEA-Dalian Biotechnological and Medical Experts Subdivision

Part 3: Late Phase Drug Discovery -Downstream

Chapter 10: Pipeline Update on IND against Major Diseases Chapter 11: Me-too Drug Discovery and Biosimilar HPV 2011 (June 11-13, 2011, Beijing, China) Chapter 12: New Drug Bioprocess and Production under GMP Standards Chapter 13: Key Issues in IND Filing and Regulatory Approval Process Chapter 14: Drug Discovery Integrative Services, Deal-Making, and Business Development Chapter 15: Pharmaceutical R & D Management and Translational Sciences China Council for the Promotion of International Trade Dalian Sub-Council Human Resources and Social Security Bureau of Shenzhen Municipality China Association for International Exchange of Personnel IDDST Congress 2011 is your best chance to showcase to drug discovery professionals in China. Developed to offer comfort to delegates while maximizing exhibitor ICM 2011 (Aug. 9-11, 2011, Beijing, China ) Find New Prospects in this Marketplace! Meet Face-to-Face with buyers across the entire life sciences R&D value chain who are seeking WCCAS 2011 (Aug. 9-11, 2011, Beijing, China ) best-in-class of drug discovery and development technologies, include leading scientists, group leaders and executives. Why Reserve Booth at IDDST-2011? IDDST 2011 is one of the world leading international events dedicated to the innovative ways to MTS 2011 (Sep.23-25, 2011, Busan, Korea) accelerate the drug discovery process, expand the clinical pipelines of promising drugs and biologics and reduce attrition of compounds due to safety and efficacy issues. Scenery of Shenzhen exposure, the coffee break, and poster sessions will all take place in the exhibition area promoting frequent repeated opportunities for delegates to visit the exhibits. Training Center of State Administration of Foreign Experts Affairs China International Talent Exchange Foundation China International Job Market

Special Symposia on Non-Human Drug Discovery

WCM 2011 (July 30-Aug. 1 , 2011, Beijing, China) Symposium 1: Veterinary Medicine Discovery and Development Symposium 2: Pesticide Discovery and Development Symposium 3: Aquaculture Biocides and Disease Prevention Drug Discovery CMCB 2011 (Aug. 6-8, 2011, Beijing, China) Exhibition and Poster

CEMD 2011 (Sep.22-24, 2011, Beijing, China) Quantum Design China

WCF 2011 (Oct. 15-17, 2011, Chongqing, China)

Windows of the World

Zoo

Ocean world

LCES 2011 (Oct.19-26, 2011, Dalian, China) Happy Valley WCPG 2011 (Oct.19-22, 2011, Dalian, China) HuaQiao City Folk Culture Villages

We welcome you to visit the tour webpage to learn more about the routes and prices. To join a tour please contact : Catherine@iddst.com

WCHFA 2011 (Oct.19-22, 2011, Dalian, China) more...

2010-2011 All right reserved for BIT Congress, Inc. Contact Us: Tel: 0086-411-84799609, Fax: 0086-411-84796897